Having trained as a neurologist with broad experience in general neurology, Dr Rachel Farrell has specialist experience in neurorehabilitation, complex spasticity management and multiple sclerosis. She completed a PhD investigating disease modifying treatments for MS in the Division of Neuroimmunology (Department of Neuroinflammation) at the UCL Institute of Neurology. After completing a fellowship in Neurorehabilitation at The National Hospital for Neurology and Neurosurgery (NHNN), Rachel was appointed as a Consultant and has gained considerable experience in both neurorehabilitation and complex spasticity management, including treatments using EMG guided botulinum toxin, intrathecal baclofen and phenol.
Current research interests focus on developing a spasticity research programme to
complement the clinical service focusing on (i) investigation of novel therapeutic agents for spasticity and (ii) improve outcome measurements. Ongoing studies include the “ITB cognition study” to evaluate the cognitive benefits of intrathecal treatment over oral agents in subjects with MS. As a sub-study the team is collecting CSF and blood samples to evaluate biomarkers of disability and cognition.